CW June 2002

category image Volume 11
Issue Number 6
June 2002
ISSN 10593802

Targeted Therapy Shrinks Advanced Lung Cancer

Another daily oral therapy targeted at tyrosine kinase, gefitinib (Iressa), can help shrink lung tumors and ease suffering for advanced cancer patients. It may provide a new way to fight lung cancer.
Go to Previous Page
Go to Next Page

Source & Additional Reading

ASCO Annual Meeting, Orlando.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW June 2002

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login